GlobalData on MSN
D3 Bio receives FDA clearance to advance KRAS inhibitor trials
The Phase II trial will assess the early efficacy, safety and pharmacokinetics of combining elisrasib with D3S 002.
Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Jacksonville Journal-Courier on MSN
Pancreatic cancer is among the deadliest cancers. A new drug is giving patients and doctors hope
The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...
Now, patients in Bay County might not have to travel far to be part of what comes next.u2028Florida Cancer Affiliates is ...
News-Medical.Net on MSN
New oral drug safely lowers triglycerides and other blood lipids in Phase 1 trial
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Two of the largest clinical trials of their kind have doused hopes that a diabetes and weight loss “wonder drug” might also work its magic on Alzheimer’s. A daily dose of oral semaglutide did not ...
FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
While helping care for cancer patients in Steamboat Springs for 19 years, oncologist and hematologist Dr. Robert Rifkin has ...
Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...
In today’s ACT Brief, we look at efforts to address sex-based evidence gaps in Parkinson’s disease research, why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results